5-Hydroxy-2'-deoxyuridine

CAS No. 5168-36-5

5-Hydroxy-2'-deoxyuridine( 5-OHdU )

Catalog No. M27060 CAS No. 5168-36-5

5-Hydroxy-2'-deoxyuridine is a major oxidation product of 2'-Deoxycytidine and can be incorporated into DNA in vitro.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 50 Get Quote
5MG 82 Get Quote
10MG 120 Get Quote
25MG 201 Get Quote
50MG 300 Get Quote
100MG 448 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    5-Hydroxy-2'-deoxyuridine
  • Note
    Research use only, not for human use.
  • Brief Description
    5-Hydroxy-2'-deoxyuridine is a major oxidation product of 2'-Deoxycytidine and can be incorporated into DNA in vitro.
  • Description
    5-Hydroxy-2'-deoxyuridine is a major oxidation product of 2'-Deoxycytidine and can be incorporated into DNA in vitro.(In Vitro):Translesion synthesis past 5-Hydroxy-2'-deoxyuridine in 18- and 45-member oligodeoxyribonucleotides occurred, but pauses both opposite, and one nucleotide prior to, the modified base in the template is observed. The specificity of nucleotide incorporation opposite 5-Hydroxy-2'-deoxyuridine in the template is sequence context-dependent. In one sequence context, dA is the principal nucleotide incorporated opposite 5-Hydroxy-2'-deoxyuridine. However, in a second sequence context, dC is the predominant base incorporated opposite 5-Hydroxy-2'-deoxyuridine. In that same sequence context, dC is also the predominant nucleotide incorporated opposite 5-Hydroxy-2'-deoxyuridine.
  • In Vitro
    To study the specificity of nucleotide incorporation opposite 5-hydroxypyrimidines in template DNA, 18- and 45-member oligodeoxyribonucleotides, containing an internal 2'-deoxy-5-hydroxyuridine (5-OHdU) in two different sequence contexts, were used. Translesion synthesis past 2'-deoxy-5-hydroxyuridine (5-OHdU) in both oligonucleotides occurred, but pauses both opposite, and one nucleotide prior to, the modified base in the template is observed. The specificity of nucleotide incorporation opposite 2'-deoxy-5-hydroxyuridine (5-OHdU) in the template is sequence context dependent. In one sequence context, dA is the principal nucleotide incorporated opposite 2'-deoxy-5-hydroxyuridine (5-OHdU). However in a second sequence context, dC is the predominant base incorporated opposite 2'-deoxy-5-hydroxyuridine (5-OHdU). In that same sequence context, dC is also the predominant nucleotide incorporated opposite 2'-deoxy-5-hydroxyuridine (5-OHdU).
  • In Vivo
    ——
  • Synonyms
    5-OHdU
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Nucleoside Antimetabolite/Analog
  • Recptor
    KCNQ1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    5168-36-5
  • Formula Weight
    244.2
  • Molecular Formula
    C9H12N2O6
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 33.33 mg/mL (136.49 mM)
  • SMILES
    O=C1N([C@@]2(O[C@H](CO)[C@@H](O)C2)[H])C=C(O)C(=O)N1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Mattmann ME, et al. Identification of (R)-N-(4-(4-methoxyphenyl)thiazol-2-yl)-1-tosylpiperidine-2-carboxamide, ML277, as a novel, potent and selective K(v)7.1 (KCNQ1) potassium channel activator. Bioorg Med Chem Lett. 2012;22(18):5936-5941.
molnova catalog
related products
  • 2′-Deoxy-2′-fluorogu...

    2′-Deoxy-2′-fluoroguanosine is a nucleoside analog that potently inhibits influenza virus A and B strains(EC90 <0.35 μM). 2'-Deoxy-2'-fluoroguanosine is an inhibitor of influenza virus replication in the upper respiratory tract, improving fever and nasal inflammation.

  • 5-Azacytidine

    A chemical analog of Cytidine that inhibits DNA methyltransferase; induces mitochondrial apoptosis and autophagy.

  • Enocitabine

    Enocitabine is a nucleoside analog. Enocitabine inhibits the replication of human cytomegalovirus(HCMV) and it also has antileukemic and antiviral activities.